Nonalcoholic fatty liver disease: A nutritional approach

Metabolic Syndrome and Related Disorders

Volumn 10, Issue 3, 2012, Pages 161-166

  Colak, Yasar ^a   Tuncer, Ilyas ^a   Senates, Ebubekir ^b   Ozturk, Oguzhan ^a   Doganay, Levent ^a   Yilmaz, Yusuf ^c  

^a ISTANBUL MEDENIYET UNIVERSITY   (Turkey)

^b HAYDARPASA NUMUNE EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^c MARMARA UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; CARBOHYDRATE; FATTY ACID; FRUCTOSE; GLUCOSE; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1BETA; PROTEIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRACE ELEMENT; VITAMIN;

CALORIC RESTRICTION; CHRONIC LIVER DISEASE; DIET; DIET SUPPLEMENTATION; FATTY LIVER; GLYCEMIC INDEX; HUMAN; HYPERTRIGLYCERIDEMIA; INFLAMMATION; INSULIN RESISTANCE; LIFESTYLE MODIFICATION; LIPOGENESIS; LIVER FIBROSIS; LOW FAT DIET; NONALCOHOLIC FATTY LIVER; NONHUMAN; NUTRITION; PATHOGENESIS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; VITAMIN D DEFICIENCY; VITAMIN INTAKE;

ANIMALS; DIET; ENERGY INTAKE; FATTY LIVER; HUMANS; LIFE STYLE; NUTRITIONAL STATUS; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; RISK REDUCTION BEHAVIOR;

EID: 84861744669     PISSN: 15404196     EISSN: 15578518     Source Type: Journal    
DOI: 10.1089/met.2011.0145     Document Type: Review

References (82)

1. MacDonald RA. Pathogenesis of nutritional cirrhosis. Arch Intern Med 1962;110:424-434.
2. Oh MK, Winn J, Poordad F. Diagnosis and treatment of nonalcoholic fatty liver disease. Aliment Pharmacol Ther 2008; 28:503-522.
3. Vernon G, Baranova A, Younossi ZM. Systematic review: The epidemiology and natural history of non-Alcoholic fatty liver disease and non-Alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 2011;34:274-285.
4. Hamaguchi M, Kojima T, Takeda N, et al. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med 2005;143:722-728.
5. Marchesini G, Brizi M, Bianchi G, et al. Nonalcoholic fatty liver disease: A feature of the metabolic syndrome. Diabetes 2001;50:1844-1850. (Pubitemid 33641605)
6. Day C, James O. Steatohepatitis: A tale of two ''hits''? Gastroenterology 1998;114:842.
7. Sanyal AJ, Campbell-Sargent C, Mirshahi F, et al. Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities. Gastroenterology 2001;120: 1183-1192. (Pubitemid 32246672)
8. Marchesini G, Bugianesi E, Forlani G, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003;37:917-923. (Pubitemid 36397405)
9. Moon KW, Leem JM, Bae SS, et al. The prevalence of metabolic syndrome in patients with nonalcoholic fatty liver disease. Korean J Hepatol 2004;10:197-206.
10. Ong JP, Elariny H, Collantes R, et al. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients. Obes Surg 2005;15:310-315. (Pubitemid 40463594)
11. Liangpunsakul S, Chalasani N. Unexplained elevations in alanine aminotransferase in individuals with the metabolic syndrome: Results from the third National Health and Nutrition Survey (NHANES III). Am J Med Sci 2005;329: 111-116. (Pubitemid 40354750)
12. Bugianesi E, Gentilcore E, Manini R, et al. A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease. Am J Gastroenterol 2005;100:1082-1090. (Pubitemid 40769045)
13. Buyken AE, Liese AD. Dietary glycemic index, glycemic load, fiber, simple sugar, and insulin resistance. Diabetes Care 2005;28:1397-1403.
14. Mezey E. Dietary fat and alcoholic liver disease. Hepatology 1998;28:901-905. (Pubitemid 28450247)
15. Hu FB, van Dam RM, Liu S. Diet and risk of type II diabetes: The role of types of fat and carbohydrate. Diabetologia 2001;44:805-817. (Pubitemid 32642452)
16. Adkins-Marshall BA, Myers SR, Hendrick GK, et al. Interaction between insulin and glucose-delivery route in regulation of net hepatic glucose uptake in conscious dogs. Diabetes 1989;39:87-95.
17. Timlin MT, Parks EJ. Temporal pattern of De novo lipogenesis in the postprandial state in healthy men. Am J Clin Nutr 2005;81:35-42. (Pubitemid 43073373)
18. Charlton M, Sreekumar R, Rasmussen D, et al. Apolipoprotein synthesis in nonalcoholic steatohepatitis. Hepatology 2002;35:898-904. (Pubitemid 34258385)
19. Westerbacka J, Lammi K, Hakkinen AM, et al. Dietary fat content modifies liver fat in overweight nondiabetic subjects. J Clin Endocrinol Metab 2005;90:2804-2809. (Pubitemid 40686327)
20. De Meijer VE, Le HD, Meisel JA, et al. Dietary fat intake promotes the development of hepatic steatosis independently from excess caloric consumption in a murine model. Metabolism 2010;59:1092-1105.
21. Wang D, Wei Y, Pagliassotti MJ. Saturated fatty acids promote endoplasmic reticulum stress and liver injury in rats with hepatic steatosis. Endocrinology 2006;147:943-951. (Pubitemid 43113013)
22. Zivkovic AM, German JB, Sanyal AJ. Comparative review of diets for the metabolic syndrome: Implications for nonalcoholic fatty liver disease. Am J Clin Nutr 2007;86: 285-300. (Pubitemid 47256910)
23. Lapointe A, Couillard C, Lemieux S. Effects of dietary factors on oxidation of low-density lipoprotein particles. J Nutr Biochem 2006;17:645-658. (Pubitemid 44380376)
24. Williams CM. Beneficial nutritional properties of olive oil: Implications for postprandial lipoproteins and factor VII. Nutr Metab Cardiovasc Dis 2001;11:51-56. (Pubitemid 33686229)
25. Rajaram S, Burke K, Connell B, et al. A monounsaturated fatty acid-rich pecan-enriched diet favorably alters the serum lipid profile of healthy men and women. J Nutr 2001;131: 2275-2279. (Pubitemid 32851868)
26. Kris-Etherton PM, Pearson TA, Wan Y, et al. High-monounsaturated fatty acid diets lower both plasma cholesterol and triacylglycerol concentrations. Am J Clin Nutr 1999;70: 1009-1015.
27. Julius U. Fat modification in the diabetes diet. Exp Clin Endocrinol Diabetes 2003;111:60-65. (Pubitemid 36505811)
28. Shapiro H, Tehilla M, Attal-Singer J, et al. The therapeutic potential of long-chain omega-3 fatty acids in nonalcoholic fatty liver disease. Clin Nutr 2010;30:6-19.
29. Cortez-Pinto H, Jesus L, Barros H, et al. How different is the dietary pattern in nonalcoholic steatohepatitis patients? Clin Nutr 2006;25:816-823. (Pubitemid 44426431)
30. Capanni M, Calella F, Biagini MR, et al. Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-Alcoholic fatty liver disease: A pilot study. Aliment Pharmacol Ther 2006;23: 1143-1151. (Pubitemid 43779354)
31. Spadaro L, Magliocco O, Spampinato D, et al. Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease. Dig Liver Dis 2008;40:194-199. (Pubitemid 351181793)
32. Zhu FS, Liu S, Chen XM, et al. Effects of n-3 polyunsaturated fatty acids from seal oils on nonalcoholic fatty liver disease associated with hyperlipidemia. World J Gastroenterol 2008; 14:6395-6400.
33. Tanaka N, Sano K, Horiuchi A, et al. Highly purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis. J Clin Gastroenterol 2008;42:413-418. (Pubitemid 351450629)
34. Sullivan S. Implications of diet on nonalcoholic fatty liver disease. Curr Opin Gastroenterol 2010;26:160-164.
35. Musso G, Gambino R, De Michieli F, et al. Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis. Hepatology 2003; 37:909-916. (Pubitemid 36397404)
36. Tetri LH, Basaranoglu M, Brunt EM, et al. Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent. Am J Physiol Gastrointest Liver Physiol 2008;295:987-995.
37. Koppe SWP, Elias M, Moseley RH, et al. Trans fat feeding results in higher serum alanine aminotransferase and increased insulin resistance compared with a standard murine high-fat diet. Am J Physiol Gastrointest Liver Physiol 2009; 297:378-384.
38. Micha R, Mozaffarian D. Trans fatty acids: Effects on metabolic syndrome, heart disease and diabetes. Nat Rev Endocrinol 2009;5:335-344.
39. Liu S, Willett WC, Stampfer MJ, et al. A prospective study of dietary glycemic load, carbohydrate intake, and risk of coronary heart disease in US women. Am J Clin Nutr 2000; 71:1455-1461. (Pubitemid 30395891)
40. Valtueña S, Pellegrini N, Ardigò D, et al. Dietary glycemic index and liver steatosis. Am J Clin Nutr 2006;84:136-142. (Pubitemid 44699177)
41. Scribner KB, Pawlak DB, Ludwig DS. Hepatic steatosis and increased adiposity in mice consuming rapidly vs. slowly absorbed carbohydrate. Obesity 2007;15:2190-2199. (Pubitemid 350004086)
42. Bugianesi E, Moscatiello S, Ciaravella MF, et al. Insulin resistance in nonalcoholic fatty liver disease. Curr Pharm Des 2010;16:1941-1951.
43. Postic C, Girard J. The role of the lipogenic pathway in the development of hepatic steatosis. Diabetes Metab 2008;34: 643-648.
44. McDevitt RM, Bott SJ, Harding M, et al. De novo lipogenesis during controlled overfeeding with sucrose or glucose in lean and obese women. Am J Clin Nutr 2001;74:737-746. (Pubitemid 33101793)
45. Havel PJ. Dietary fructose: Implications for dysregulation of energy homeostasis and lipid/carbohydrate metabolism. Nutr Rev 2005;63:133-157.
46. Zelber-Sagi S, Nitzan-Kaluski D, Goldsmith R, et al. Long term nutritional intake and the risk for non-Alcoholic fatty liver disease (NAFLD): A population based study. J Hepatol 2007;47:711-717. (Pubitemid 47503432)
47. Spruss A, Bergheim I. Dietary fructose and intestinal barrier: Potential risk factor in the pathogenesis of nonalcoholic fatty liver disease. J Nutr Biochem 2009;20:657-662.
48. Abid A, Taha O, Nseir W, et al. Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome. J Hepatol 2009;51:918-924.
49. Abdelmalek MF, Suzuki A, Guy C, et al. Steatohepatitis Clinical Research Network. Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease. Hepatology 2010;51:1961-1971.
50. Elliott SS, Keim NL, Stern JS, et al. Fructose, weight gain, and the insulin resistance syndrome. Am J Clin Nutr 2002;76:911-922. (Pubitemid 35244659)
51. Assy N, Nasser G, Kamayse I, et al. Soft drink consumption linked with fatty liver in the absence of traditional risk factors. Can J Gastroenterol 2008;22:811-816.
52. Ouyang X, Cirillo P, Sautin Y, et al. Fructose consumption as a risk factor for non-Alcoholic fatty liver disease. J Hepatol 2008;48:993-999.
53. Nagai Y, Yonemitsu S, Erion DM, et al, The role of peroxisome proliferator activated receptor gcoactivator-1 b in the pathogenesis of fructose-induced insulin resistance. Cell Metab 2009;9:252-264.
54. Rodríguez-Calvo R, Barroso E, Serrano L, et al. Atorvastatin prevents carbohydrate response element binding protein activation in the fructose-fed rat by activating protein kinase A. Hepatology 2009;49:106-115.
55. Linn T, Santosa B, Gronemeyer D, et al. Effect of long-Term dietary protein intake on glucose metabolism in humans. Diabetologia 2000;43:1257-1265.
56. Schulze MB, Manson JE, Willett WC, et al. Processed meat intake and incidence of type 2 diabetes in younger and middle-Aged women. Diabetologia, 2003, 46:1465-1473. (Pubitemid 37518567)
57. C.T. Kappagoda, D.A. Hyson, E.A. Amsterdam. Lowcarbohydrate-high-protein diets: Is there a place for them in clinical cardiology? J Am Coll Cardiol 2004;43:725-730. (Pubitemid 38296466)
58. Alvarez JA, Ashraf A. Role of vitamin d in insulin secretion and insulin sensitivity for glucose homeostasis. Int J Endocrinol 2010;2010:351-385.
59. Targher G, Bertolini L, Scala L, et al. Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with nonalcoholic fatty liver disease. Nutr Metab Cardiovasc Dis 2007;17:517-524. (Pubitemid 47176859)
60. Katz K, Brar PC, Parekh N, et al. Suspected nonalcoholic fatty liver disease is not associated with vitamin d status in adolescents after adjustment for obesity. J Obes 2010; 2010:496829.
61. Lavine JE. Vitamin E treatment of nonalcoholic steatohepatitis in children: A pilot study. J Pediatr 2000;136:734-738. (Pubitemid 30415645)
62. Harrison SA, Torgerson S, Hayashi P, et al. Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis. Am J Gastroenterol 2003;98:2485-2490. (Pubitemid 37448761)
63. Nobili V, Manco M, Devito R, et al. Effect of vitamin E on aminotransferase levels and insulin resistance in children with non-Alcoholic fatty liver disease. Aliment Pharmacol Ther 2006;24:1553-1561. (Pubitemid 44915203)
64. Sanyal AJ, Chalasani N, Kowdley KV, et al. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med 2010;362:1675-1685.
65. Capristo E, Miele L, Forgione A, et al. Nutritional aspects in patients with non-Alcoholic steatohepatitis (NASH). Eur Rev Med Pharmacol Sci 2005;9:265-268. (Pubitemid 41387389)
66. Drenick EJ, Simmons F, Murphy JF. Effect on hepatic morphology of treatment of obesity by fasting, reducing diets and small-bowel bypass. N Engl J Med 1970;282: 829-830.
67. Weiner RA. Surgical treatment of non-Alcoholic steatohepatitis and non-Alcoholic fatty liver disease. Dig Dis 2010;28: 274-279.
68. Liu X, Lazenby AJ, Clements RH, et al. Resolution of nonalcoholic steatohepatitis after gastric bypass surgery. Obes Surg 2007;17:486-492. (Pubitemid 46850188)
69. Furuya CK, De Oliveira CP, De Mello ES, et al. Effects of bariatric surgery on nonalcoholic fatty liver disease: Preliminary findings after 2 years. J Gastroenterol Hepatol 2007;22:510-514. (Pubitemid 46434992)
70. De Luis DA, Aller R, Izaola O, et al. Effect of a hypocaloric diet in transaminases in nonalcoholic fatty liver disease and obese patients, relation with insulin resistance. Diabetes Res Clin Pract 2008;79:74-78.
71. Dixon JB, Bhathal PS, Hughes NR, O'Brien PE. Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss. Hepatology 2004;39:1647-1654. (Pubitemid 38702666)
72. Ueno T, Sugawara H, Sujaku K, et al. Therapeutic effects of restricted diet and exercise in obese patients with fatty liver. J Hepatol 1997;27:103-107. (Pubitemid 27357062)
73. Yancy WS, Olsen MK, Guyton JR, et al. A low-carbohydrate, ketogenic diet versus a low-fat diet to treat obesity and hyperlipidemia: A randomized, controlled trial. Ann Intern Med 2004;140:769-777.
74. Huang MA, Greenson JK, Chao C, et al. One-year intense nutritional counseling results in histological improvement in patients with nonalcoholic steatohepatitis: A pilot study. Am J Gastroenterol 2005;100:1072-1080.
75. Stewart KJ, Bacher AC, Turner K, et al. Exercise and risk factors associated with metabolic syndrome in older adults. Am J Prev Med 2005;28:9-18. (Pubitemid 40051320)
76. Wadden TA, Butryn ML, Wilson C. Lifestyle modification for the management of obesity. Gastroenterology 2007;132:2226-2238. (Pubitemid 46693750)
77. Spate-Douglas T, Keyser RE. Exercise intensity: Its effect on the highdensity lipoprotein profile. Arch Phys Med Rehabil 1999;80:691-695. (Pubitemid 29269653)
78. Suzuki A, Lindor K, St. Saver J, et al. Effect of changes on body weight and lifestyle in nonalcoholic fatty liver disease. J Hepatol 2005;43:1060-1066. (Pubitemid 41627993)
79. Kugelmas M, Hill DB, Vivian B, at al. Cytokines and NASH: A pilot study of the effects of lifestyle modification and vitamin E. Hepatology, 2003, 38:413-419. (Pubitemid 36919862)
80. Sreenivasa BC, Alexander G, Kalyani B, et al. Effect of exercise and dietary modification on serum aminotransferase levels in patients with nonalcoholic steatohepatitis. J Gastroenterol Hepatol 2006;21:191-198.
81. Bellentani S, Dalle Grave R, Suppini A, et al. Fatty Liver Italian Network. Behavior therapy for nonalcoholic fatty liver disease: The need for a multidisciplinary approach. Hepatology 2008;47:746-754. (Pubitemid 351280743)
82. Thomas EL, Brynes AE, Hamilton G, et al. Effect of nutritional counselling on hepatic, muscle and adipose tissue fat content and distribution in nonalcoholic fatty liver disease. World J Gastroenterol 2006;12:5813-5819. (Pubitemid 44594249)